1. DNA programmed Mg-Al layered double hydroxide-based bi-adjuvant nanovaccines.
- Author
-
Dong, Yuhang, Chen, Ling, Hou, Junwei, Sun, Yun, Han, Zibo, Zhang, Jing, Liang, Yu, Feng, Yongjun, Ren, Jin, Li, Qiming, Nie, Guangjun, and Li, Feng
- Subjects
IMMUNOLOGICAL adjuvants ,LAYERED double hydroxides ,CELLULAR immunity ,IMMUNE response ,TOLL-like receptors - Abstract
Implementation of adjuvants is a requirement for inducing antigen-specific immune responses against infectious diseases. The conventional aluminum adjuvants used in clinical trials suffer from insufficient cellular immune response. Herein, we develop a bi-adjuvant nanovaccine containing receptor-binding domain (RBD) as antigen and DNA programmed Mg/Al layered double hydroxide (Mg/Al-LDH) as adjuvants, and thus achieve co-activation of potent humoral and cellular immune responses. The Mg/Al-LDH consisting of positively charged layers is firstly employed as scaffold to adsorb antigen via electrostatic interaction, and then CpG and dendritic cell (DC)-targeting aptamers co-encoded ultra-long DNA chains are easily decorated on the Mg/Al-LDH via interfacial assembly. The nanoscale formulations and interfacial targeting aptamers of nanovaccine facilitate their endocytosis by DC cells; the Mg/Al-LDH structure is acid-responsive and ensures the Al ions-inducing antigen cross-presentation for durable generation of antibody (Th2 immune response); and the agonist CpG in DNA chains can bind to the Toll-like receptor 9 (TLR 9) to activate cellular immunity (Th1 immune response). The bi-adjuvant nanovaccine fully combines the advantages of nanosheet alum-like adjuvant and precisely customization of DNA, and thus balances the Th1/Th2 immune response for compensating the deficiency of traditional alum adjuvant, providing a design guidance for creating next-generation of safe and efficient adjuvants in immunology. [Display omitted] • The nanovaccine was constructed using LDH as a scaffold which adsorbed DNA chains and RBD antigens byinterfacial assembly. • The DNA-LDH facilitated the endocytosis and cross presentation of RBD antigens. • The DNA-LDH achieved co-activation of potent humoral and cellular immune responses. • The DNA-LDH balanced the Th1/Th2 immune response which compensated the deficiency of traditional alum adjuvant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF